Subscribe to RSS
DOI: 10.1055/s-0038-1661032
Selective PF4 Release In Vitro Induced by Heparin and Related Glycosaminoglycans (GAGs) - Correlation with β-TG Release and Platelet Aggregation
Publication History
Received 18 July 1983
Accepted 07 December 1983
Publication Date:
19 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198401/lookinside/thumbnails/10-1055-s-0038-1661032-1.jpg)
Summary
We studied human platelet aggregation and β-TG/PF4 release induced by heparin and related GAGs in vitro both in normal PRP and in PRP after aspirin. In our experimental conditions, heparin and related GAGs always caused PF4 release in vitro from normal platelets, whether or not there was measurable platelet aggregation in the aggregometer. Significant β-TG release was induced only by the mucosal heparin preparation (which also induced platelet aggregation in some citrated PRP). Therefore, while β-TG release in vitro seems to correlate with platelet aggregating activity of heparin, the selective PF4 release, caused by heparin and related GAGs also in conditions in which neither platelet aggregation nor β-TG are measurable, is probably associated with the high affinity of PF4 for heparin. The degree of affinity of GAGs for PF4 (heparin > DeS > HS) seems to correlate with PF4 release. Moreover, the significant reduction in PF4 release in vitro after aspirin suggests that GAGs-induced PF4 release is related to a cyclooxygenase-dependent activation process.
-
References
- 1 Anseil J, Slepchuk N, Kumar R, Lopez A, Southard L, Deykin D. Heparin induced thrombocytopenia: a prospective study. Thromt Haemostas 1980; 43: 61-65
- 2 Bell WR, Royall RM. Heparin associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980; 303: 902-907
- 3 Bjoraker DG, Ketcham TR. Hemodynamic and platelet response to the bolus intravenous administration of porcine heparin. Thromb Haemostas 1983; 49: 1-4
- 4 Busch C, Dawes J, Pepper DS, Wasteson A. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 1980; 19: 129-137
- 5 Carreras LO. Thrombosis and thrombocytopenia induced by heparin. Scand J Haematol 1980; 36 (suppl) 64-80
- 6 Celia G, Menardo A, Girolami A. Effect of heparin on in vivo platelet factor 4 (PF4) release and platelet aggregation after aspirin administration. Clin Lab Haematol 1980; 2: 333-338
- 7 Chong BH, Grace CS, Rozenberg MC. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets. Br J Haematol 1981; 49: 531-540
- 8 Chong BH, Pitney WR, Castaldi PA. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induced thromboxane synthesis and platelet aggregation. Lancet 1982; 1: 1246-1248
- 9 Cines DB, Kaywin P, Bina M, Tomaski A, Schreiber AD. Heparin- associated thrombocytopenia. N Engl J Med 1980; 303: 788-795
- 10 Cofrancesco E, Radaelli F, Pogliani E, Amici N, Torn GG, Casu B. Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet aggregating activities Thromb Res 1979; 14: 179-187
- 11 Dawes J, Smith RC, Pepper DS. The release, distribution and clearance of human β-thromboglobulin and platelet factor 4. Thromb Res 1978; 12: 851-861
- 12 Handin RI, Cohen HJ. Purification and binding properties of human platelet factor 4. J Biol Chem 1976; 251: 4273-4282
- 13 Handin RI, Jordan R, Rosenberg RD. Biochemistry of platelet factor 4. In: The Chemistry and Biology of Heparin. Lundblad RL, Brown WV, Mann KG, Roberts HR. (eds) Elsevier/North Holland Press; New York: 1981. pp 393-401
- 14 Huisse MG, Guilin MC, Bezeaud A, Toulemon F, Kitzis M, Andreassian B. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions Thromb Res 1982; 27: 485-490
- 15 Janson PA, Moake JL, Carpinito G. Aspirin prevents heparin- induced platelet aggregation in vivo. Br J Haematol 1983; 53: 166-168
- 16 Mastacchi R, Stanzani L, Barbanti M, Montecchi L, Bianchini P. Interaction of heparin and heparin fractions with human platelets. Thromb Res 1982; 28: 275-280
- 17 McLean MR, Hause LL. Heparin-induced aggregation of normal human platelets. Thromb Haemostas 1981; 46: 570
- 18 Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64-73